INTERNATIONAL PATENT: SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED, 上海湃隆生物科技有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION CONTAINING PRMT5 INHIBITOR AND PD-1/PD-L1 INHIBITOR"

Posted On: 2025-08-10

GENEVA, Aug. 10 -- SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED (Unit C101, 1976 Gaoke Zhong Road, Pilot Free TradePudong New Area, Shanghai 201210), 上海湃隆生物科技有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区高科中路1976号1幢C101室) filed a patent application (PCT/CN2025/074930) for "PHARMACEUTICAL COMPOSITION CONTAINING PRMT5 INHIBITOR AND PD-1/PD-L1 INHIBITOR" on Jan 24, 2025. With publication no. WO/2025/162314, the details related to the patent application was published on Aug 07, 2...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED, 上海湃隆生物科技有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION CONTAINING PRMT5 INHIBITOR AND PD-1/PD-L1 INHIBITOR"